{
  "case_id": "MN13-15237",
  "year": 2013,
  "patient_info": {
    "age_range": "51 to 64",
    "gender": "Female"
  },
  "diagnosis": "Immuno Disorders",
  "secondary_conditions": [],
  "complications": [],
  "symptoms": [],
  "treatment_category": "Pharmacy",
  "treatment_subcategory": "Other",
  "treatments_requested": [
    {
      "name": "H.P. Acthar Gel",
      "drug_type": "other",
      "procedure_type": null,
      "is_procedure": false,
      "other_or_notes": "Requested for treatment of systemic lupus erythematosus (SLE)"
    }
  ],
  "treatments_tried_but_failed": [],
  "treatments_tried_and_worked": [],
  "treatments_not_tried": [
    {
      "name": "High-Dose Corticosteroids",
      "drug_type": "standard",
      "procedure_type": null,
      "is_procedure": false,
      "other_or_notes": "Significant potential toxicities"
    },
    {
      "name": "cyclophosphamide",
      "drug_type": "standard",
      "procedure_type": null,
      "is_procedure": false,
      "other_or_notes": "Significant potential toxicities"
    },
    {
      "name": "Rituximab",
      "drug_type": "standard",
      "procedure_type": null,
      "is_procedure": false,
      "other_or_notes": "Significant potential toxicities"
    }
  ],
  "is_denial_upheld": false,
  "issues_considered": [
    "medical_necessity"
  ],
  "other_issues": null,
  "guidelines_support": null,
  "guidelines_not_support": null,
  "guidelines_details": null,
  "soc_support": null,
  "soc_not_support": null,
  "soc_details": null,
  "study_support": true,
  "study_details": [
    {
      "study_name": "Drug Des Devel Ther",
      "study_authors": "Bomback et al",
      "key_findings": "Partial or complete remission in 11 out of 21 patients with nephrotic syndrome; proteinuria reduced to less than 500 mg/24 hours in four patients."
    },
    {
      "study_name": "Am J Nephrol",
      "study_authors": "Bomback et al",
      "key_findings": "In a study of 15 patients with resistant glomerular disease, two of five resistant membranous nephropathy patients achieved clinical remission."
    }
  ],
  "key_questions": [
    "medical_necessity"
  ],
  "expedited": false,
  "rationale": "The physician reviewer found that the submitted documentation demonstrates the medical necessity of Acthar gel for controlling the patient's proteinuria. Alternative therapies have significant potential toxicities.",
  "reviewer_credentials": null
}